Rabavert rabies vacc w-diluents
Ended Awarded Last action
- Contract number
- SPE2DR26F74GK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,406
Award facts
- Contract value 100% obligated
- $22,406.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,406 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on January 22, 2026, with an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the AmerisourceBergen brand name), is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and extending through December 2026. The prime IDC enables the contractor to supply a broad range of pharmaceutical products and medical commodities—including specialty medications, vaccines, and related supplies—to support military healthcare programs worldwide and serve customers including the Defense Health Agency and the U.S. Coast Guard. The vaccine delivery under this order fulfills medical supply needs as part of the company's extensive federal contract portfolio across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F74GK?
SPE2DR26F74GK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F74GK worth?
The government has obligated $22,406 on SPE2DR26F74GK.
Is contract SPE2DR26F74GK an order under another contract?
Yes. SPE2DR26F74GK is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F74GK competed?
The extent of competition for SPE2DR26F74GK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award